Saltar al contenido
Radio Logo
PodcastsEducaciónESC TV Today – Your Cardiovascular News

ESC TV Today – Your Cardiovascular News

European Society of Cardiology
Último episodio

132 episodios

  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.19: Extended interview on pulmonary hypertension: what's new?

    12/11/2026 | 24 min
    Host: Rasha Al-Lamee
    Guest: Stephan Rosenkranz
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2553
    Want to watch that extended interview on pulmonary hypertension: what's new?, go to: https://esc365.escardio.org/event/2553?resource=interview
    Disclaimer:
    ESC TV Today is supported by Eli Lilly and Company, Novartis and Novo Nordisk through independent funding. The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. 
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.
    Declarations of interests:
    Stephan Achenbach, Dan Atar, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    Rasha Al-Lamee has declared to have potential conflicts of interest to report: speaker's fees for Menarini Pharmaceuticals, Abbott, Philips, Medtronic, Servier, Shockwave, Elixir; advisory board: Janssen Pharmaceuticals, Abbott, Philips, Shockwave, CathWorks, Elixir, Astrazeneca; consulting fees: Menarini Pharmaceuticals, Abbott, Philips, Shockwave, Elixir, IsomAB, VahatiCor, SpectraWave, AstraZeneca, Cathworks, Janssen Pharmaceuticals; CEO of ORBITA Systems Ltd. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. 
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Stephan Rosenkranz has declared to have potential conflicts of interest to report: remunerations for lectures and/or consultancy from Abbott, Acceleron, Actelion, Aerovate, AOP, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, DaiichiSankyo, Edwards, Ferrer, Gossamer, Inari, Inhibikase, Janssen, Lilly, Liquidia, MSD, Novartis, NovoDordisk, OMT, Orphacare, Pfizer, United Therapeutics. Research grants to institutions: AstraZeneca, Bayer, Janssen, Lempo, MSD.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.19: Chasing the vulnerable plaque - Pulmonary hypertension: what's new?

    12/11/2026 | 23 min
    This episode covers:
    Cardiology this Week: A concise summary of recent studies
    Chasing the vulnerable plaque
    Pulmonary hypertension: what's new?
    Spotlight: Kounis syndrome
    Host: Rasha Al-Lamee
    Guests: Carlos Aguiar, David Newby, Stephan Rosenkranz
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2553
    Want to watch that extended interview on pulmonary hypertension, go to: https://esc365.escardio.org/event/2553?resource=interview
     
    Disclaimer 
    ESC TV Today is supported by Eli Lilly and Company, Novartis and Novo Nordisk through independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Dan Atar, Yasmina Bououdina, Nicolle Kraenkel and David Newby have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    Rasha Al-Lamee has declared to have potential conflicts of interest to report: speaker's fees for Menarini Pharmaceuticals, Abbott, Philips, Medtronic, Servier, Shockwave, Elixir; advisory board: Janssen Pharmaceuticals, Abbott, Philips, Shockwave, CathWorks, Elixir, Astrazeneca; consulting fees: Menarini Pharmaceuticals, Abbott, Philips, Shockwave, Elixir, IsomAB, VahatiCor, SpectraWave, AstraZeneca, Cathworks, Janssen Pharmaceuticals; CEO of ORBITA Systems Ltd.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Stephan Rosenkranz has declared to have potential conflicts of interest to report: remunerations for lectures and/or consultancy from Abbott, Acceleron, Actelion, Aerovate, AOP, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, DaiichiSankyo, Edwards, Ferrer, Gossamer, Inari, Inhibikase, Janssen, Lilly, Liquidia, MSD, Novartis, NovoDordisk, OMT, Orphacare, Pfizer, United Therapeutics. Research grants to institutions: AstraZeneca, Bayer, Janssen, Lempo, MSD.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.18: Extended interview on atrial mitral regurgitation

    29/10/2026 | 8 min
    Host: Rick Grobbee
    Guest: Denisa Muraru
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2557
    Want to watch that extended interview on atrial mitral regurgitation, go to: https://esc365.escardio.org/event/2557?resource=interview
     
    Disclaimer 
    ESC TV Today is supported by Eli Lilly and Company, Novartis and Novo Nordisk through independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails. 
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Dan Atar, Yasmina Bououdina, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. 
    Denisa Muraru has declared to have potential conflicts of interest to report: speaker's fees for General Electric, Philips, Edwards. 
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.quibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Episode 18 - Atrial mitral regurgitation - Cardiac protection in cancer patients

    29/10/2026 | 21 min
    This episode covers:
    Cardiology this Week: A concise summary of recent studies
    Cardioprotection in cancer patients
    Atrial mitral regurgitation
    Milestones: SPAF-I
    Host: Rick Grobbee
    Guests: Carlos Aguiar, Alexander Lyon, Denisa Muraru
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2557 
    Want to watch that extended interview on atrial mitral regurgitation, go to: https://esc365.escardio.org/event/2557?resource=interview
     
    Disclaimer 
    ESC TV Today is supported by Eli Lilly and Company, Novartis and Novo Nordisk through independent funding.
    The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    All declarations of interest are listed at the end of the episode.
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production.
    All content is reviewed and approved by the editorial team.
    Statements and opinions expressed by guest speakers are their own.
     
    Declarations of interests
    Stephan Achenbach, Dan Atar, Yasmina Bououdina, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Alexander Lyon has declared to have potential conflicts of interest to report: speaker, advisory board, or consultancy fees and/or research grants from Nordic Pharma, Janssen-Cilag Ltd, Astellas Pharma, Pfizer, Novartis, Servier, AstraZeneca, Bristol Myers Squibb, GSK, Amgen, Takeda, Roche, Clinigen Group, Eli Lilly, Eisai Ltd, Ferring Pharmaceuticals, Boehringer Ingelheim, Akcea Therapeutics, Aktiia, Myocardial Solutions, iOWNA Health, Heartfelt Technologies Ltd, ARMA Biosciences, and EPICLIFE.
    Denisa Muraru has declared to have potential conflicts of interest to report: speaker's fees for General Electric, Philips, Edwards. 
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.quibb-Pfizer, Johnson & Johnson.
  • ESC TV Today – Your Cardiovascular News

    Season 4 - Ep.17: Extended interview on 'The price of performance': doping and the athlete's heart

    15/10/2026 | 10 min
    Host: Rasha Al-Lamee
    Guest: Sanjay Sharma
    Want to watch that episode? Go to: https://esc365.escardio.org/event/2550
    Want to watch that extended interview on The price of performance: doping and the athlete's heart, go to: https://esc365.escardio.org/event/2550?resource=interview
    Disclaimer:
    ESC TV Today is supported by Novartis and Novo Nordisk through independent funding. The programme has not been influenced in any way by its funding partners.
    This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. 
    The ESC is not liable for any translated content of this video. The English language always prevails.
    ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.
    Declarations of interests:
    Stephan Achenbach, Dan Atar, Yasmina Bououdina, Nicolle Kraenkel and Sanjay Sharma have declared to have no potential conflicts of interest to report.
    Rasha Al-Lamee has declared to have potential conflicts of interest to report:speaker's fees for Menarini pharmaceuticals, Abbott, Philips, Medtronic, Servier, Shockwave, Elixir. Advisory board: Janssen Pharmaceuticals, Abbott, Philips, Shockwave, CathWorks, Elixir, Astrazeneca. Consulting Fees: Menarini pharmaceuticals, Abbott, Philips, Shockwave, Elixir, IsomAB, VahatiCor, SpectraWave, AstraZeneca, Cathworks, Janssen Pharmaceuticals; CEO of ORBITA Systems Ltd.
    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.
    John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.
    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.
    David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.
    Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.
    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.
    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Más podcasts de Educación
Acerca de ESC TV Today – Your Cardiovascular News
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, HFA Cardio Talk and much more. Check them out!
Sitio web del podcast

Escucha ESC TV Today – Your Cardiovascular News, CAMINO AL ÉXITO por BRIAN TRACY y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
ESC TV Today – Your Cardiovascular News: Podcasts del grupo